Tower Research Capital (TRC)’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.06K Buy
+121
New +$3.06K ﹤0.01% 4580
2026
Q1
Sell
-1,146
Closed -$29.2K 5302
2025
Q4
$29.2K Sell
1,146
-2,227
-66% -$56.7K ﹤0.01% 2826
2025
Q3
$86.1K Sell
3,373
-1,138
-25% -$28.9K ﹤0.01% 2123
2025
Q2
$115K Buy
4,511
+277
+7% +$6.98K ﹤0.01% 2266
2025
Q1
$107K Buy
+4,234
New +$106K ﹤0.01% 1738

Other funds holding IBDT

Tower Research Capital (TRC)'s IBDT Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in iShares iBonds Dec 2028 Term Corporate ETF (IBDT) in Q2 2026: 121 shares worth $3.06K. The stake represents ﹤0.01% of the portfolio and ranks #4580 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in IBDT as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in IBDT in Q1 2025 and has held it in 5 quarters since. The position peaked at $115K in Q2 2025. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Tower Research Capital (TRC) held 121 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $3.06K as of Q2 2026.
  • iShares iBonds Dec 2028 Term Corporate ETF was a new Tower Research Capital (TRC) position in Q2 2026.
  • iShares iBonds Dec 2028 Term Corporate ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4580 holding.
  • Tower Research Capital (TRC) first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q1 2025 and has held it in 5 quarters since.
  • Tower Research Capital (TRC)'s iShares iBonds Dec 2028 Term Corporate ETF position peaked at $115K in Q2 2025.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.